This problem is apparently resolved in the case of SCLC because of both SCLC's chemosensitivity and deficiency of retinoblastoma (RB) tumor suppressor protein, which theoretically minimize concerns of anti-tumor efficacy [7]. This evidence concerns the gene TCHP and small cell lung carcinoma.